Staff exchange programme
An international and multidisciplinary staff exchange programme from 23 partners in 8 Eu/non-Eu countries
Newborn screening, diagnosis and treatment of sickle cell disease
Newborn screening, early diagnosis and appropriate treatments will improve patients’ quality of life.
Collaborative research and training initiatives
Different educational initiatives will be promoted to foster scientific cooperation and build research capacity.
Arise Project
African Research and Innovative Initiative for Sickle cell Education:
Improving Research Capacity for Service Improvement
ARISE is a research project recently funded by the EU in the framework of the H2020-MSCA-RISE-2018 programme aimed at creating an interagency and multidisciplinary staff exchange programme between experienced researchers, early start investigators and other relevant staff members of the partners institutions to share and spread the best practices in Newborn Screening, diagnosis and treatment of the Sickle Cell Disease, leading to improvement in overall disease outcome.
Arise Project
What is the
Sickle Cell Disease (SCD)
The Sickle Cell Disease (SCD) is a group of inherited red blood cells disorders. People who have sickle cell disease have an abnormal protein in their red blood cells.
This is a disease until a few decades ago almost unknown in Europe, and now is considered one of the most relevanthematological emergencies.
Latest News & Events
Keep updated on all the initiatives and events of the ARISE project
Save the date: COVID-19 and Sickle Cell Disease: the current scenario – session 2
The second session of the webinar, to be held on Thursday 28th May, 2020 at 04:00 PM (UK time), will be the occasion to discuss with some relevant experts in the field who will provide their experience in order to understand the impact of COVID-19 on the SCD population, drawing conclusions from both the US and Lebanon. The emotional impact of the disease and the current response of the community in the US will be addressed as well.
Save the date: COVID-19 and Sickle Cell Disease: the current scenario – session 1
We are pleased to invite you to join the webinar “COVID-19 and Sickle Cell Disease: the current scenario”, organised within the ARISE project. The first session of the webinar will be held on Tuesday 19th May, 2020 at 04:00 PM (UK time). Relevant experts in the field of the haemoglobinopathies will give their contribution to understand the impact of the COVID-19 on the Sickle Cell Disease population and to compare the current pandemic response from the UK, Italy and Ghana, outlining the lessons learnt.
Novartis’ Expert Advice on Sickle Cell Disease
Some useful suggestions were provided to help patients to prevent or to face complications such as the pulmonary ones.
from the blog
Learn more about ARISE project
Comfort’s secondment experience
Comfort’s secondment experience at the Royal College of Pathologists (London, UK).
Ifeoma’s Secondment to the UK
Ifeoma’s secondment experience in UK.
Moses’ secondment experience
Moses’ secondment experience at The London School of Hygiene & Tropical Medicine in London (UK).